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To the editor,
Thrombocytopenia before and after iron therapy 
has been reported in children with severe iron defi-
ciency anemia (IDA), but the association and mech-
anism  of  action  are  not  well  established  [1-6]. 
Herein we present 2 children with IDA that had low 
platelet and leukocyte counts at presentation (n=1) 
and  following  oral  iron  therapy  (n=1).  Written 
informed consent was obtained from the patient.
Case 1
A 7-year-old boy with pica presented with a diag-
nosis  of  leukemia.  He  did  not  have  hepatospleno-
megaly,  lymphadenopathy,  or  infection.  Laboratory 
results were as follows: hemoglobin (Hb): 6.9 g/dL; 
mean corpuscular volume (MCV): 66 fL; red cell dis-
tribution  width  (RDW):  20.3%.  Iron  studies  results 
were  consistent  with  iron  deficiency,  as  follows: 
serum iron: 13 μg/dL; total iron binding capacity: 416 
μg/dL;  ferritin  level:  10  ng/mL.  The  patient’s  white 
blood cell (WBC) count was 2.9×103/μL (1.5×103/μL 
neutrophils) and platelet count was 28×103/μL. Bone 
marrow  aspiration  showed  a  normal  number  of 
megakaryocytes, low-level stored iron, and no blasts. 
The patient was diagnosed as IDA. On d 5 of iron 
treatment the patient’s findings were as follows: Hb: 
7.4 g/dL; MCV: 68 fL; RDW: 25.7%; WBC: 5.6×103/μL; 
platelet count: 430×103/μL. 
Case 2
A 2-year-old boy presented with fatigue, pallor, 
diminished  appetite,  and  irritability.  Laboratory 
results were as follows: Hb: 5.3 g/dL; MCV: 54.5 fL; 
RDW: 32.5%; WBC: 8.4×103/μL; and platelet count: 
769×103/μL.  Iron  study  results  were  as  follows: 
serum iron: 7 μg/dL; total iron binding capacity: 423 
μg/dL; ferritin level: 1.8 ng/mL. On d 6 of iron treat-
ment there was a sudden decrease in his platelet 
count (31×103/μL), but he had no signs of infection 
and viral serology was negative. Bone marrow aspi-
ration  showed  a  normal  number  of  megakaryo-
cytes, low-level stored iron, and no blasts. After iron 
therapy his platelet count was 194×103/μL on d 10, 
and 382×103/μL on d 12. 
Discussion
Thrombocytopenia is an uncommon manifesta-
tion  of  iron  deficiency  (2%  of  IDA  patients)  [7]. Perlman  et  al.  reported  6  children  with  IDA  and 
thrombocytopenia  with  a  mean  platelet  count  of 
64×109/L.  After  initiation  of  oral  iron  therapy  the 
patients had rapid increases in their platelet counts. 
The researchers speculated that iron-dependent pro-
cesses critical to thrombopoiesis were altered [3]. 
The  mechanism  of  thrombocytopenia  in  iron 
deficiency  might  be  an  early  response  to  direct 
stimulation of the EPO receptor on megakaryocytes 
or shunting into the erythroid precursors pathway, 
leading  to  decreased  platelet  formation  [8]. 
Leukopenia may also occur in patients with IDA [3], 
though the exact mechanism is unclear; alteration 
in the activity of iron-dependent enzymes in leuco-
poiesis may be the cause. Animal experiments and 
in vitro studies have demonstrated that administra-
tion  of  erythropoietin  down-regulated  neutrophil 
production [9].
In conclusion, the 2 presented cases had a very 
common disease, but uncommon findings. IDA and 
iron  therapy  may  be  associated  with  decreased 
platelet and leucocyte counts. 
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